Fernando Estévez-López

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Fernando (Fer) Estévez-López, PhD, is the Marie Sklodowska-Curie (COFUND) Postdoctoral Fellow at Erasmus MC University Medical Center in Rotterdam, The Netherlands.

Estévez-López was the project manager of the al-Andalus Project at the University of Granada (Spain). This project is an epidemiological study, a gene study, and an exercise-based randomized controlled trial (RCT) study on a representative sample of women with fibromyalgia from southern Spain.[1]

EUROMENE[edit | edit source]

Estévez-López is the leader of the Working Group on Epidemiology of ME/CFS across Europe on behalf of the EUROMENE, a European Union COST Action CA15111 not-for-profit research organization investigating the cause of and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[2]

Education[edit | edit source]

(As per EUROMENE CV[1] and ResearchGate[3])

  • 2010, BSc - Sport Sciences, School of Sport Sciences, University of Granada, Granada, Spain
  • 2011, MSc - Master in Research Methods on Physical Activity and Sport, School of Sport Sciences, University of Granada, Granada, Spain
  • 2012, MSc - Postgraduate course on Applied Statistic, UNED, The Spanish Open University, Madrid, Madrid, Spain
  • 2014, MSc - Master in Cognitive and Behavioral Neuroscience, School of Psychology, University of Granada, Granada, Spain
  • 2018, PhD

Notable studies[edit | edit source]


Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

randomized controlled trial (RCT) - A trial in which participants are randomly assigned to two groups, with one group receiving the treatment being studied and a control or comparison group receiving a sham treatment, placebo, or comparison treatment.

randomized controlled trial (RCT) - A trial in which participants are randomly assigned to two groups, with one group receiving the treatment being studied and a control or comparison group receiving a sham treatment, placebo, or comparison treatment.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

BMJ - The BMJ (previously the British Medical Journal) is a weekly peer-reviewed medical journal.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.